about
Retinoic acid modulates the asialoglycoprotein receptor expression in cultured fetal rat hepatocytes.Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological statesExtracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection.Characterization of transglutaminase type II role in dendritic cell differentiation and function.Type 2 transglutaminase and cell death.AMBRA1 and SQSTM1 expression pattern in prostate cancer.ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells.Localization and interaction of bovine pancreatic trypsin inhibitor and tryptase in the granules of bovine mast cells.Induction of autophagy promotes the growth of early preneoplastic rat liver nodules.Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois.Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition.Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions.Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress.Energy metabolism and re-establishment of intercellularadhesion complexes of gel entrapped hepatocytesType 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins.Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis.Cat-to-human orthopoxvirus transmission, northeastern Italy.Monoamine oxidase A and B activities in embryonic chick hepatocytes: differential regulation by retinoic acid.Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics.The simultaneous exposition of galactose and mannose-specific receptors on rat liver macrophages is developmentally regulated.Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells.Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix.Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: A biochemical and ultra-structural study in humansTauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural studyBile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cellsToxic effects of expanded ataxin-1 involve mechanical instability of the nuclear membraneTelavancin and daptomycin activity against meticillin-resistant Staphylococcus aureus strains after vancomycin-resistance selection in vitroLiver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C.Human Kupffer cell recognition and phagocytosis of apoptotic peripheral blood lymphocytesExpression of the asialoglycoprotein receptor in cultured rat hepatocytes is modulated by cell densityMore than two sides of a coin? How to detect the multiple activities of type 2 transglutaminaseFatal sclerosing peritonitis associated with primary effusion lymphoma after liver transplantation: a case reportATP-binding cassette transporter 1 and transglutaminase 2 act on the same genetic pathway in the apoptotic cell clearanceTwo cases of giant cell hepatitis in HIV-infected patientsPublisher Correction: Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
P50
Q31863162-123AA0D7-B18F-469A-83D4-0D4F4991D6FEQ34478514-97481DAC-BD63-4E60-AFFE-80EFA55C662AQ34517980-93D4DDC5-3702-4892-8BC5-A1C907929627Q35208371-BECD4F23-F383-4FDD-9D2B-ADD0A328DC39Q35534802-EFF0E9AA-151E-4048-BCEE-AA0168EC6577Q36061280-8B7D3436-A7A9-46B8-BAFD-E9398E674C6FQ36149486-C80B2DB9-0E1A-4F81-B327-AD8D983EE8E7Q36235479-03D4B9E4-55F9-4964-A8EF-8158831F4957Q36678237-2D211FFD-E12E-4205-8CD9-8FFFC8587181Q36905775-7DDED050-6E85-44A4-8248-47B12A8F60D6Q38254983-122B796C-5B8A-495F-84AC-C1904A32B827Q39602259-5E89AEA5-D3FA-46F2-BA9F-C49D79FD41C8Q40678374-329D5981-391D-45CA-A87A-11AA8819B535Q40725013-DEE9FD53-503B-41C9-B514-411D2A57D6DDQ42050085-DC1D1030-A54C-4DE6-BEFC-3475E44DD0E4Q42064407-809E42B8-EAC2-4F4A-83A8-88DA04BD4A66Q42204560-A3796AE5-5926-45C3-9DEE-31A106A9F17AQ43129027-1746F96F-55C3-498E-8699-92BF053055E3Q43973246-5A1D5363-7A80-4352-9BCC-F4B63BB0E6DBQ45423935-D9A9D727-54D6-4BDE-8FB1-6C90808276A4Q46254043-B20E7728-E0A0-4CC9-8436-97C1C2C624FAQ47367907-1B1BF0F8-9969-4DF1-8098-21972AD38384Q51833370-C2E515F0-2CCC-4FFC-9BC6-42D7F159B978Q54600809-9092A8CF-970D-43CB-BFB9-37480C968BFEQ57791913-576A83DD-10D5-46D2-AE22-30BA84A61053Q57792015-9EBF741E-10A5-4646-BEE0-3E9065748972Q57792073-EE349FC9-0731-4FC5-888C-80FC0D048BA8Q57980137-AF993C6C-BD3A-4522-9996-8A980691CBB0Q58371674-30F75D4A-FF49-4D5B-BC1B-D24C3E5B2383Q64917749-E3B80541-6249-4E0D-878B-FB941A8C92B0Q71033970-2D425705-60BC-44B9-A9B5-095DE0ED4BC7Q73136700-141B1B1A-E655-4C33-8325-A315DED0B510Q81710167-8CCEE01D-9C46-4CCB-BC07-020681A1C8C9Q82540820-8C718CF9-935D-43E7-90DD-7E3B23B80999Q83324098-039A7DA4-7C5E-4A8E-8FE9-9C83DF5936E2Q84660444-A1FB5D60-6A2C-4B73-BA8F-86DEB3C757D7Q92932757-B9DD3DE9-C185-4117-BB37-50B595BEE3AA
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Laura Falasca
@ast
Laura Falasca
@en
Laura Falasca
@es
Laura Falasca
@nl
Laura Falasca
@sl
type
label
Laura Falasca
@ast
Laura Falasca
@en
Laura Falasca
@es
Laura Falasca
@nl
Laura Falasca
@sl
prefLabel
Laura Falasca
@ast
Laura Falasca
@en
Laura Falasca
@es
Laura Falasca
@nl
Laura Falasca
@sl
P106
P21
P31
P496
0000-0001-8752-2415